Isatuximab Plus Bortezomib, Lenalidomide, and Dexamethasone (Isa-VRd) Versus Vrd in Chinese Patients with Newly Diagnosed Multiple Myeloma Who Are Ineligible for Transplant: IMROZ Subgroup Analysis

被引：0

作者：

An, Gang ^{[1
]}

Liu, Zhuogang ^{[2
]}

Jin, Jie ^{[3
]}

Cai, Zhen ^{[4
]}

Li, Wei ^{[5
]}

Xia, Zhongjun ^{[6
]}

Cen, Xinan ^{[7
]}

Hu, Yu ^{[8
]}

Mi, Jian-Qing ^{[9
]}

Jing, Hongmei ^{[10
]}

Zhan, Rong ^{[11
]}

Qu, Xiaoyan ^{[12
]}

Du, Xin ^{[13
]}

Gao, Dan ^{[14
]}

Zhao, Liang ^{[15
]}

Qiu, Lugui ^{[1
]}

机构：

[1] Inst Hematol & Blood Dis Hosp, Dept Haematol, Tianjin, Peoples R China

[2] China Med Univ, Dept Hematol, Shengjing Hosp, Shenyang, Peoples R China

[3] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Dept Hematol, Hangzhou, Peoples R China

[4] Zhejiang Univ, Affiliated Hosp 1, Dept Haematol, Hangzhou, Peoples R China

[5] Bethune First Hosp Jilin Univ, Dept Haematol, Changchun, Peoples R China

[6] Sun Yat Sen Univ, Dept Hematol Oncol, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China,Canc Ctr, Guangzhou, Peoples R China

[7] Peking Univ First Hosp, Dept Haematol, Beijing, Peoples R China

[8] Huazhong Univ Sci & Technol, Union Hosp, Inst Hematol, Tongji Med Coll, Wuhan, Peoples R China

[9] Ruijin Hosp Affiliated Shanghai Jiao Tong Univ Sch, Shanghai Inst Hematol, Natl Res Ctr Translat Med Shanghai, Natl Res Ctr Translat Med Shanghai,State Key Lab M, Shanghai, Peoples R China

[10] Peking Univ Third Hosp, Dept Hematol, Beijing, Peoples R China

[11] Fujian Med Univ, Union Hosp, Dept Haematol, Fuzhou, Peoples R China

[12] Southeast Univ, Zhongda Hosp, Nanjing 210000, Jiangsu, Peoples R China

[13] Guangdong Prov Peoples Hosp, Dept Haematol, Guangzhou, Peoples R China

[14] Sanofi, Beijing, Peoples R China

[15] Sanofi Res & Dev, Shanghai, Peoples R China

来源：

BLOOD | 2024年 / 144卷

关键词：

D O I：

10.1182/blood-2024-199908

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：7055 / 7056

页数：2